290 related articles for article (PubMed ID: 12084002)
1. Antibiotics in the treatment of acute exacerbations of chronic bronchitis.
Dever LL; Shashikumar K; Johanson WG
Expert Opin Investig Drugs; 2002 Jul; 11(7):911-25. PubMed ID: 12084002
[TBL] [Abstract][Full Text] [Related]
2. The diagnosis and treatment of elderly patients with acute exacerbation of chronic obstructive pulmonary disease and chronic bronchitis.
Albertson TE; Louie S; Chan AL
J Am Geriatr Soc; 2010 Mar; 58(3):570-9. PubMed ID: 20398122
[TBL] [Abstract][Full Text] [Related]
3. Etiology, susceptibility, and treatment of acute bacterial exacerbations of complicated chronic bronchitis in the primary care setting: ciprofloxacin 750 mg b.i.d. versus clarithromycin 500 mg b.i.d. Bronchitis Study Group.
Anzueto A; Niederman MS; Tillotson GS
Clin Ther; 1998; 20(5):885-900. PubMed ID: 9829441
[TBL] [Abstract][Full Text] [Related]
4. Role of oral extended-spectrum cephems in the treatment of acute exacerbation of chronic bronchitis.
Anzueto A; Bishai WR; Pottumarthy S
Diagn Microbiol Infect Dis; 2007 Mar; 57(3 Suppl):31S-38S. PubMed ID: 17349461
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
[TBL] [Abstract][Full Text] [Related]
6. Acute exacerbation of chronic bronchitis: a primary care consensus guideline.
Brunton S; Carmichael BP; Colgan R; Feeney AS; Fendrick AM; Quintiliani R; Scott G
Am J Manag Care; 2004 Oct; 10(10):689-96. PubMed ID: 15521160
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic activity of telithromycin and comparators against bacterial pathogens isolated from 3,043 patients with acute exacerbation of chronic bronchitis.
Sethi S; Anzueto A; Farrell DJ
Ann Clin Microbiol Antimicrob; 2005 Mar; 4():5. PubMed ID: 15755326
[TBL] [Abstract][Full Text] [Related]
8. Discrepancy between antibiotics administered in acute exacerbations of chronic bronchitis and susceptibility of isolated pathogens in respiratory samples: multicentre study in the primary care setting.
Querol-Ribelles JM; Molina J; Naberan K; Esteban E; Herreras A; Garcia-de-Lomas J
Int J Antimicrob Agents; 2006 Nov; 28(5):472-6. PubMed ID: 17046209
[TBL] [Abstract][Full Text] [Related]
9. Acute exacerbation of chronic bronchitis. Guidelines for antibiotic selection.
Schwarzmann SW
Postgrad Med; 2000 Dec; 108(7 Suppl Contemporaty):25-9. PubMed ID: 19667546
[TBL] [Abstract][Full Text] [Related]
10. [Clinical contribution of the newer fluoroquinolones in acute bacterial exacerbation of chronic bronchitis].
Niederman MS
Medicina (B Aires); 1999; 59 Suppl 1():23-30. PubMed ID: 10436551
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic therapy for exacerbations of chronic obstructive pulmonary disease (COPD).
Butorac-Petanjek B; Parnham MJ; Popovic-Grle S
J Chemother; 2010 Oct; 22(5):291-7. PubMed ID: 21123150
[TBL] [Abstract][Full Text] [Related]
12. A 1-year community-based health economic study of ciprofloxacin vs usual antibiotic treatment in acute exacerbations of chronic bronchitis: the Canadian Ciprofloxacin Health Economic Study Group.
Grossman R; Mukherjee J; Vaughan D; Eastwood C; Cook R; LaForge J; Lampron N
Chest; 1998 Jan; 113(1):131-41. PubMed ID: 9440580
[TBL] [Abstract][Full Text] [Related]
13. Comparison of first-line with second-line antibiotics for acute exacerbations of chronic bronchitis: a metaanalysis of randomized controlled trials.
Dimopoulos G; Siempos II; Korbila IP; Manta KG; Falagas ME
Chest; 2007 Aug; 132(2):447-55. PubMed ID: 17573508
[TBL] [Abstract][Full Text] [Related]
14. Infectious exacerbations of chronic bronchitis: diagnosis and management.
Sethi S
J Antimicrob Chemother; 1999 Mar; 43 Suppl A():97-105. PubMed ID: 10225579
[TBL] [Abstract][Full Text] [Related]
15. Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the respiratory surveillance program study: microbiology from the medical office practice environment.
Pfaller MA; Ehrhardt AF; Jones RN
Am J Med; 2001 Dec; 111 Suppl 9A():4S-12S; discussion 36S-38S. PubMed ID: 11755437
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and treatment of upper respiratory tract infections in the primary care setting.
Fendrick AM; Saint S; Brook I; Jacobs MR; Pelton S; Sethi S
Clin Ther; 2001 Oct; 23(10):1683-706. PubMed ID: 11726004
[TBL] [Abstract][Full Text] [Related]
17. Gemifloxacin: a new fluoroquinolone approved for treatment of respiratory infections.
Yoo BK; Triller DM; Yong CS; Lodise TP
Ann Pharmacother; 2004; 38(7-8):1226-35. PubMed ID: 15187209
[TBL] [Abstract][Full Text] [Related]
18. Gemifloxacin use in the treatment of acute bacterial exacerbation of chronic bronchitis.
Jivcu C; Gotfried M
Int J Chron Obstruct Pulmon Dis; 2009; 4():291-300. PubMed ID: 19684863
[TBL] [Abstract][Full Text] [Related]
19. Prulifloxacin versus levofloxacin in the treatment of severe COPD patients with acute exacerbations of chronic bronchitis.
Blasi F; Schaberg T; Centanni S; Del Vecchio A; Rosignoli MT; Dionisio P
Pulm Pharmacol Ther; 2013 Oct; 26(5):609-16. PubMed ID: 23538168
[TBL] [Abstract][Full Text] [Related]
20. Treatment of acute bacterial exacerbations of chronic bronchitis.
Siempos II; Michalopoulos A; Falagas ME
Expert Opin Pharmacother; 2009 May; 10(7):1173-82. PubMed ID: 19405791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
